Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.
about
Synthesis and cytotoxicity of a biotinylated CC-1065 analogueA pretargeting system for tumor PET imaging and radioimmunotherapyRadioimmunotherapy of human tumoursImproving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORFPretargeted radioimmunotherapy for hematologic and other malignanciesComparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer PatientsImproved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.Biodistribution and clearance of small molecule hapten chelates for pretargeted radioimmunotherapy.Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.Pretargeted molecular imaging and radioimmunotherapy.Pretargeted Imaging and Therapy.Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
P2860
Q24800845-19804A1C-270E-472A-95FD-71EFFE009C56Q28087820-603F6555-B6CD-4CD0-B5A1-C18F38E7126CQ28088825-FC1B4DF0-0932-4CCC-8EE9-B3E6E5325006Q33645793-F8C3803A-27CE-429D-8654-530775A7FC27Q34039426-D05B997A-719D-4FB4-9124-4A90D2C03040Q34113941-984AB17C-A452-46C6-953F-FCB493FCD0F2Q35849837-8AAED722-C45A-4A76-9E33-8266A4680090Q36082355-6ACFA890-F392-4D2A-8047-A2B9164C9D34Q36323585-AFDEE907-9CB1-41B1-A86C-96E6152AD153Q36979699-03F185B4-3CFF-4134-B01E-CF23B0EAF271Q37201878-621FE68B-11B3-40E7-BFC5-552F50489A17Q37207310-1DA44C64-39C2-40B7-9443-91AFE3D2FC3EQ37656465-E3E711B1-D3E5-4041-9200-7DFDDCF42EAEQ37720857-B63752F2-F682-4656-A888-834D56A7540DQ38022016-9BA07665-DE99-441F-B2E6-C858C90169BAQ39421977-874F9850-5A84-4D87-A311-ADF13E1A948EQ40976323-6D346193-1405-4C18-B893-976876A85E17
P2860
Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@ast
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@en
type
label
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@ast
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@en
prefLabel
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@ast
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@en
P2093
P1476
Pretargeted radioimmunotherapy ...... 131I-labeled bivalent hapten.
@en
P2093
Gautherot E
Le Doussal JM
P304
P407
P577
2000-03-01T00:00:00Z